BRIM Biotechnology, Inc. (TPE:6885)
Taiwan
· Delayed Price · Currency is TWD 21.85
-0.60 (-2.67%)
At close: May 13, 2025
BRIM Biotechnology Revenue
BRIM Biotechnology had revenue of 100.00K TWD in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 433.00K, up 381.11% year-over-year. In the year 2024, BRIM Biotechnology had annual revenue of 333.00K with 270.00% growth.
Revenue (ttm)
433.00K
Revenue Growth
+381.11%
P/S Ratio
6,844.67
Revenue / Employee
13.53K
Employees
32
Market Cap
2.96B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 87.67M |
| Oneness Biotech | 117.33M |
| Pegavision | 6.69B |
| Center Laboratories | 1.63B |